Eli Lil­ly ties up 2022 by ex­pand­ing deal with bat­tered RNA-edit­ing biotech

De­spite a year lit­tered with set­backs, Pro­QR Ther­a­peu­tics is clos­ing 2022 on a high note.

The Dutch biotech is ex­pand­ing its RNA edit­ing col­lab­o­ra­tion with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER